GLP-1-related hair shedding is most often linked to rapid weight loss or reduced calorie and nutrient intake, rather than proven direct damage to hair follicles. The usual pattern is telogen effluvium, a temporary form of diffuse shedding. Evidence published in 2026 adds to the picture, but it still does not show that GLP-1 medications directly damage hair follicles.
GLP-1-related hair shedding does not affect everyone, and it does not automatically mean permanent baldness.
GLP-1 Hair Loss at a Glance
| Question | Short answer |
|---|---|
| Can GLP-1 drugs cause hair loss? | Hair loss has been reported in clinical trials and observational studies. |
| Which drugs are involved? | Most evidence concerns semaglutide, including Ozempic and Wegovy, and tirzepatide, including Mounjaro and Zepbound. |
| Is it usually permanent? | No. Diffuse shedding caused by telogen effluvium is usually temporary. |
| Why might it happen? | Rapid weight loss, lower food intake, insufficient protein or nutrients, and possibly a direct medication effect may all play a role. |
| Should you stop the medication? | No. Speak with the prescribing clinician before changing or stopping treatment. |
How Often Does Hair Loss Occur With Wegovy and Zepbound?
Hair loss is listed as an adverse reaction for both drugs, although the reported rates come from separate trials.
The prescribing information for Wegovy, which contains semaglutide, reports hair loss in 3.3% of adults taking the 2.4 mg dose, compared with 1% of adults taking placebo in pooled weight-management studies. The FDA label states that these reactions were associated with weight reduction.
The prescribing information for Zepbound, which contains tirzepatide, also links hair loss with weight reduction. In pooled clinical trials, hair loss was reported in 7.1% of female Zepbound users and 1.3% of females receiving placebo. Among males, the figures were 0.5% and 0%, respectively.
These percentages should not be used to rank Wegovy against Zepbound because the drugs were studied in different trials. They show that hair loss is a recognized possible reaction, not that everyone taking a GLP-1 drug will experience it.
Why Can GLP-1 Drugs Trigger Hair Shedding?
Rapid weight loss is the leading explanation. It can temporarily shift more hairs into the resting phase of the growth cycle, causing telogen effluvium. Eating much less can also reduce the protein, iron and other nutrients needed for normal hair growth.
Researchers have not ruled out a direct effect from GLP-1 medications. Current evidence does not clearly show that semaglutide or tirzepatide directly damages hair follicles. The American Academy of Dermatology says more research is needed to separate the effects of the medication, weight loss and reduced food intake. A combination of factors may be involved.
What Does GLP-1-Related Hair Loss Look Like?
Telogen effluvium usually causes diffuse shedding across the scalp rather than one isolated bald patch. Common signs include:
- More hair in the shower, brush, pillow or sink
- Thinning across the scalp
- Shedding that begins several months after the trigger
- No scarring of the scalp
The American Academy of Dermatology notes that excessive shedding often appears a few months after a physical stressor. Hair commonly regains its usual fullness within six to nine months as the body readjusts, although the timeline can vary.
Does Hair Grow Back After GLP-1 Hair Loss?
Hair usually grows back when the shedding is telogen effluvium. Regrowth may begin before the shedding stops, but restoring visible density can take several months.
Hair loss may continue if the trigger remains. Possible triggers include ongoing rapid weight loss, inadequate nutrition, iron deficiency, thyroid disease, illness or severe stress. A dermatologist can distinguish temporary shedding from conditions such as androgenetic alopecia or alopecia areata.
What Does Newer Research Say?
Newer research supports an association between GLP-1 drugs and hair loss, but it does not settle the question of direct causation.
A 2026 BMJ target-trial emulation found that adults with type 2 diabetes who started GLP-1 receptor agonists had a higher incidence of clinically recorded hair loss than similar patients who started SGLT-2 or DPP-4 inhibitors. The association was mainly with non-scarring alopecia, and the researchers described the absolute risk as low. Because the study was observational, it could not prove that GLP-1 medication caused the hair loss.
A 2026 systematic review and meta-analysis also found a higher risk of reported hair loss among GLP-1 receptor agonist users than among placebo users, with an estimated event rate of about 3.9%. The studies had limitations, including differences in drug dose, weight loss, patient characteristics and how hair loss was diagnosed.
What Should You Do if Your Hair Starts Shedding?
If your hair starts shedding after you begin or increase a GLP-1 medication, take these steps:
Do not stop Ozempic, Wegovy, Mounjaro, Zepbound or another prescribed GLP-1 drug without speaking with your clinician. Stopping treatment can affect blood sugar or weight management.
Tell the prescriber when the shedding began. The timing of dose increases, appetite changes and weight loss may help identify the likely trigger.
Review your nutrition. Ask your clinician or a registered dietitian how to maintain adequate protein, calories and nutrients while losing weight.
Consider a medical evaluation if the shedding is heavy. A clinician may check for other causes, including iron deficiency, thyroid problems, illness, hormonal changes or hereditary hair loss.
See a dermatologist if the hair loss is severe or persistent. A dermatologist can determine whether the problem is temporary shedding or a separate hair-loss disorder.
When Is Hair Loss Less Typical of Telogen Effluvium?
Round or sharply defined bald patches, eyebrow or eyelash loss, and scalp pain, redness, scaling or scarring are less typical of telogen effluvium. Seek medical advice promptly if you notice any of the following:
- Round or sharply defined bald patches
- Loss of eyebrows or eyelashes
- Scalp pain, redness, scaling or scarring
- Sudden, severe hair loss
- Hair loss that keeps worsening or does not improve over time
- Other symptoms such as marked fatigue, cold intolerance or heavy menstrual bleeding
Bottom Line
Hair shedding after a GLP-1 dose increase deserves a review of the timing, weight change and nutritional intake. Keep taking the medication as prescribed until you have spoken with the prescriber, unless they give you different instructions. Seek dermatology care for bald patches, scalp changes or shedding that continues to worsen.